Compare FLOC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLOC | LAB |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.4M | 449.9M |
| IPO Year | 2025 | 2011 |
| Metric | FLOC | LAB |
|---|---|---|
| Price | $17.91 | $1.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $30.17 | $1.35 |
| AVG Volume (30 Days) | 283.7K | ★ 2.1M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.78% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $748,499,000.00 | $169,737,000.00 |
| Revenue This Year | $43.28 | N/A |
| Revenue Next Year | $7.88 | N/A |
| P/E Ratio | $13.10 | ★ N/A |
| Revenue Growth | 76.22 | ★ 79.77 |
| 52 Week Low | $14.03 | $0.92 |
| 52 Week High | $30.50 | $2.25 |
| Indicator | FLOC | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 62.29 |
| Support Level | $16.41 | $1.28 |
| Resistance Level | $19.10 | $1.56 |
| Average True Range (ATR) | 0.75 | 0.09 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 65.68 | 66.22 |
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.